POU6F2 mutation identified in humans with pubertal failure shifts isoform formation and alters GnRH transcript expression

Idiopathic hypogonadotropic hypogonadism (IHH) is characterized by absent pubertal development and infertility, often due to gonadotropin-releasing hormone (GnRH) deficits. Exome sequencing of two independent cohorts of IHH patients identified 12 rare missense variants in POU6F2. POU6F2 encodes two distinct isoforms. In mouse, pituitary and gonads expressed both isoforms, but only isoform1 was detected in GnRH cells. Although the function of isoform2 is well known, using bioinformatics and cells assays on a human-derived GnRH cell line, we demonstrate isoform1 can also act as a transcriptional regulator, decreasing GNRH1 expression. The impact of two POU6F2 variants (MT1 and MT2) was then examined. MT1, but not MT2, reduced transcriptional activity of either isoform, preventing Hes5 promoter activation by isoform2 and repression of GnRH transcripts by isoform1. GnRH transcription increases as the cells migrate into the brain. Augmentation earlier can disrupt normal GnRH cell migration, consistent with POU6F2 variants contributing to IHH pathogenesis.

[1]  M. Barnes,et al.  Whole exome sequencing identifies deleterious rare variants in CCDC141 in familial self-limited delayed puberty , 2021, NPJ genomic medicine.

[2]  J. Casanova,et al.  The genetic structure of the Turkish population reveals high levels of variation and admixture , 2021, Proceedings of the National Academy of Sciences.

[3]  H. Schöler,et al.  Biological importance of OCT transcription factors in reprogramming and development , 2021, Experimental & Molecular Medicine.

[4]  Hyung-Goo Kim,et al.  Genetics of hypogonadotropic Hypogonadism—Human and mouse genes, inheritance, oligogenicity, and genetic counseling , 2021, Molecular and Cellular Endocrinology.

[5]  M. Gowing,et al.  Natural language generation from class diagrams , 2011, MoDeVVa.

[6]  A. Juul,et al.  Minipuberty of human infancy – A window of opportunity to evaluate hypogonadism and differences of sex development? , 2020, Annals of pediatric endocrinology & metabolism.

[7]  Yumeng Yan,et al.  The HDOCK server for integrated protein–protein docking , 2020, Nature Protocols.

[8]  Vojtech Adam,et al.  Ten quick tips for homology modeling of high-resolution protein 3D structures , 2020, PLoS Comput. Biol..

[9]  Hongyun Wang,et al.  Identification of a novel somatic mutation of POU6F2 by whole‐genome sequencing in prolactinoma , 2019, Molecular genetics & genomic medicine.

[10]  L. Dunkel,et al.  Delayed Puberty—Phenotypic Diversity, Molecular Genetic Mechanisms, and Recent Discoveries , 2019, Endocrine reviews.

[11]  Yang Zhang,et al.  Template‐based and free modeling of I‐TASSER and QUARK pipelines using predicted contact maps in CASP12 , 2018, Proteins.

[12]  Lin Li,et al.  Predicting protein‐DNA binding free energy change upon missense mutations using modified MM/PBSA approach: SAMPDI webserver , 2018, Bioinform..

[13]  Mateusz Kurcinski,et al.  CABS-flex 2.0: a web server for fast simulations of flexibility of protein structures , 2018, Nucleic Acids Res..

[14]  B. I. Hutchins,et al.  CCDC141 Mutations in Idiopathic Hypogonadotropic Hypogonadism , 2017, The Journal of clinical endocrinology and metabolism.

[15]  Pei Zhou,et al.  HDOCK: a web server for protein–protein and protein–DNA/RNA docking based on a hybrid strategy , 2017, Nucleic Acids Res..

[16]  J. Michael Cherry,et al.  Evaluating the clinical validity of gene-disease associations: an evidence-based framework developed by the Clinical Genome Resource , 2017, bioRxiv.

[17]  Evan Z. Macosko,et al.  A Molecular Census of Arcuate Hypothalamus and Median Eminence Cell Types , 2017, Nature Neuroscience.

[18]  Gao Wang,et al.  The impact of rare variation on gene expression across tissues , 2016, Nature.

[19]  B. I. Hutchins,et al.  CCDC141 Mutation Identified in Anosmic Hypogonadotropic Hypogonadism (Kallmann Syndrome) Alters GnRH Neuronal Migration. , 2016, Endocrinology.

[20]  R. Palmiter,et al.  Fertility-Regulating Kiss1 Neurons Arise from Hypothalamic Pomc-Expressing Progenitors , 2015, The Journal of Neuroscience.

[21]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[22]  E. Dermitzakis,et al.  Tissue-Specific Effects of Genetic and Epigenetic Variation on Gene Regulation and Splicing , 2015, PLoS genetics.

[23]  K. Horiguchi,et al.  Molecular Cloning of Rat and Porcine Retina-derived POU Domain Factor 1 (POU6F2) from a Pituitary cDNA Library , 2014, The Journal of reproduction and development.

[24]  David A. Knowles,et al.  Allelic Expression of Deleterious Protein-Coding Variants across Human Tissues , 2014, PLoS genetics.

[25]  Kaare Teilum,et al.  Protein stability, flexibility and function. , 2011, Biochimica et biophysica acta.

[26]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[27]  P. Travers,et al.  Novel Mechanisms of Fibroblast Growth Factor Receptor 1 Regulation by Extracellular Matrix Protein Anosmin-1* , 2009, The Journal of Biological Chemistry.

[28]  J. H. Pereira,et al.  Structure of human Brn-5 transcription factor in complex with CRH gene promoter. , 2009, Journal of structural biology.

[29]  Xiang-Jun Lu,et al.  Web 3DNA—a web server for the analysis, reconstruction, and visualization of three-dimensional nucleic-acid structures , 2009, Nucleic Acids Res..

[30]  G. M. Leclerc,et al.  Identification of a novel OCT1 binding site that is necessary for the elaboration of pulses of rat GnRH promoter activity , 2005, Molecular and Cellular Endocrinology.

[31]  M. Dattani,et al.  Novel mutations within the POU1F1 gene associated with variable combined pituitary hormone deficiency. , 2005, The Journal of clinical endocrinology and metabolism.

[32]  W. Crowley,et al.  Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. , 2002, The Journal of clinical endocrinology and metabolism.

[33]  S. Radovick,et al.  Identification of a discrete promoter region of the human GnRH gene that is sufficient for directing neuron-specific expression: a role for POU homeodomain transcription factors. , 2002, Molecular endocrinology.

[34]  M Wilmanns,et al.  Differential dimer activities of the transcription factor Oct-1 by DNA-induced interface swapping. , 2001, Molecular cell.

[35]  A. Herbison,et al.  Regulation of Gonadotropin-Releasing Hormone (GnRH) Gene Expression during GnRH Neuron Migration in the Mouse , 2001, Neuroendocrinology.

[36]  M. Rosenfeld,et al.  POU domain factors in the neuroendocrine system: lessons from developmental biology provide insights into human disease. , 2001, Endocrine reviews.

[37]  S. Wray,et al.  Novel gene expressed in nasal region influences outgrowth of olfactory axons and migration of luteinizing hormone-releasing hormone (LHRH) neurons. , 2000, Genes & development.

[38]  S. Wray,et al.  Transcription factor activator protein-2 is required for continued luteinizing hormone-releasing hormone expression in the forebrain of developing mice. , 2000, Endocrinology.

[39]  M. Rosenfeld,et al.  A model for the development of the hypothalamic–pituitary axis: transcribing the hypophysis , 1999, Mechanisms of Development.

[40]  M. Rosenfeld,et al.  POU domain family values: flexibility, partnerships, and developmental codes. , 1997, Genes & development.

[41]  S. Ojeda,et al.  Repression of gonadotropin-releasing hormone promoter activity by the POU homeodomain transcription factor SCIP/Oct-6/Tst-1: a regulatory mechanism of phenotype expression? , 1997, Molecular and cellular biology.

[42]  J. Nathans,et al.  Retina-derived POU-domain factor-1: a complex POU-domain gene implicated in the development of retinal ganglion and amacrine cells , 1996, Journal of Neuroscience.

[43]  W. Herr,et al.  The POU domain: versatility in transcriptional regulation by a flexible two-in-one DNA-binding domain. , 1995, Genes & development.

[44]  B. Rubin,et al.  Dynamic alterations in luteinizing hormone-releasing hormone (LHRH) neuronal cell bodies and terminals of adult rats , 1995, Cellular and Molecular Neurobiology.

[45]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.

[46]  R. Wallace Is this a practical approach? , 2001, Journal of the American College of Surgeons.